Precigen, Inc.

NASDAQ:PGEN

Biotechnology

Healthcare
$4.16 -2.08%

-$0.10 today

Market cap
$1.49B
Beta
1.06
P/E (TTM)
-7.1
EPS (TTM)
-$0.65
52W Low $1.39High $5.47

Volume 4.37M

Average 4.72M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$87.83M

FY 2025 · Annual

Investing Cash Flow

-$1.53M

FY 2025 · Annual

Financing Cash Flow

$90.05M

FY 2025 · Annual

-18.6% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(92.17M)28.32M(95.9M)(126.24M)(250.64M)
Depreciation & Amortization13.76M10.77M6.67M4.53M3.2M
Deferred Income Tax(167K)(150K)(479K)(1.8M)0
Stock-Based Compensation13.9M10.21M9.89M9.47M10.87M
Change in Working Capital(804K)(35.7M)17.07M4.52M6.62M
Accounts Receivables(6.56M)(13.51M)12.23M414K(3.2M)
Inventory(1.9M)2.34M00(9.21M)
Accounts Payables420K379K(2.42M)1.55M8.77M
Other Working Capital7.24M(24.91M)7.26M2.56M10.26M
Other Non-Cash Items9.7M(78.48M)(4.17M)41.34M142.12M
Operating Cash Flow(55.77M)(65.05M)(66.93M)(68.17M)(87.83M)
Capital Expenditures(7.25M)(4.92M)(1.54M)(8.58M)(2M)
Acquisitions (Net)00000
Purchases of Investments(174.22M)0(185.03M)(187.21M)(208.01M)
Sales of Investments100.17M68.44M183.38M175.02M208.47M
Other Investing Activities6.76M162.9M98K60K0
Investing Cash Flow(74.54M)226.42M(3.09M)(20.71M)(1.54M)
Debt Repayment(466K)(155.29M)(43.22M)092.82M
Common Stock Issued121.05M072.81M31.24M310K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities608K1K0346K(3.08M)
Financing Cash Flow121.19M(155.29M)29.59M110.58M90.05M
Effect of Forex Changes217K(827K)(320K)(27K)35K
Net Change in Cash(8.91M)5.25M(40.75M)21.67M717K
Free Cash Flow(63.02M)(69.97M)(68.47M)(76.76M)(89.83M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$250.6M
+ D&A$3.2M
+ Stock-Based Comp$10.9M
+ Deferred Tax$0
+ Working Capital$6.6M
+ Other Non-Cash$142.1M
= Operating Cash Flow-$87.8M
- Capex-$2.0M
= Free Cash Flow-$89.8M

Analysis

FY2025 free cash flow is -$89.8M. FCF conversion is 35.8% of net income. Operating cash flow was -$87.8M, with capex of -$2.0M. The largest bridge item is Other Non-Cash at $142.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipSep 24, 2026
4Statement of changes in beneficial ownershipAug 28, 2026
4Statement of changes in beneficial ownershipAug 25, 2026

Does PGEN generate free cash flow?

Precigen, Inc. (PGEN) generated -$89.83M of free cash flow in fiscal 2025.

How much operating cash flow does PGEN produce?

Operating cash flow was -$87.83M, before capital expenditures of $2.00M.